CRTH2-IN-1 (Ramatroban analog) is a selectiveprostaglandin D2 receptor DP2(CRTH2) antagonist with an IC₅₀of 6 nM in a human DP2 binding assay.

CRTH2-IN-1 (Ramatroban analog, Compound 5) is a novel prostaglandin D2 receptor DP2 (CRTH2) antagonist with an IC₅₀of 7 nM in a human whole blood eosinophil shape change assay (hESC). CRTH2-IN-1 (Ramatroban analog) is a novel tricyclic antagonist of the prostaglandin D2 receptor DP2 (CRTH2) with efficacy in a murine model of allergic rhinitis. Human prostaglandin D1 receptor (hDP1) binding is performed using³H-PGD2 and human platelet membranes. Human thromboxane receptor (hTP) binding performed using human platelet membranes and³H-SQ-29,548. Human prostacyclin receptor (hIP) binding perfomed using hIP/293 membranes and³Hiloprost. CRTH2-IN-1 inhibits hDP1 binding with an IC₅₀of 1μM. CRTH2-IN-1 inhibits hTP and hIP binding with IC₅₀s of >100 μM. CRTH2-IN-1 inhibits human CYP isoforms CYP3A4, CYP 2C9 and CYP2D6 with IC₅₀s of 7, 5 and >30 μM, respectively^[1].

416.47

C₂₁H₂₁FN₂O₄S

926661-54-3

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.